RFK Jr.'s peptide policy could boost Hims & Hers as its GLP-1 business evolves - CNBC

1. RFK Jr.'s peptide policy could boost Hims & Hers as its GLP-1 business evolves  CNBC
2. Hims & Hers stock jumps as U.S. moves forward with plan to reassess popular peptides  MarketWatch
3. The Trump administration is looking to experts to weigh in on peptides  Scientific American
4. FDA advisory committee set to weigh taking action on certain unapproved peptides  Fierce Pharma
5. FDA moves toward easing restrictions on certain peptides  BioPharma Dive